Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
RLIP76 is a stress‐responsive membrane protein implicated in the regulation of multiple cellular signaling pathways. It represents the predominant glutathione‐conjugate (GS‐E) transporter in cells. We have shown that RLIP76 plays a crucial role in defending cancer cells from radiation and chemotherapeutic toxin‐mediated apoptosis, and that its inhibition by antibodies or depletion by siRNA or antisense causes apoptosis in a number of cancer cell types. We demonstrated for the first time that the striking anti‐neoplastic effects with no evident toxicity in terms of either weight loss or metabolic effects are also demonstrable for the antibody, antisense and siRNA in a renal cell xenografts model of Caki‐2 cells (Singhal et al., Cancer Res., 2009, 69: 4244). Present studies were performed to determine if RLIP76 targeting is more broadly applicable in other kidney cancer cell lines, to compare the signaling effects of RLIP76 antisense with kinase inhibitors used in treatment of renal cell carcinoma, and to determine whether kinase inhibitors were substrates for transport by RLIP76. Results of these studies show that sorafenib as well as sunitinib are substrates for transport by RLIP76 thus are competitive inhibitors of GS‐E transport. Furthermore, kinase inhibition in the ERK as well as PI3K pathways by RLIP76 depletion is more profound and consistent and is more widely apparent in a number of renal carcinoma cell lines. These studies offer strong support for our overall hypothesis that RLIP76 is an overarching anti‐apoptosis mechanism that, if inhibited, can be more broadly effective in the treatment of renal cell carcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer
Thomas, G. V., Tran, C., Mellinghoff, I. K., Welsbie, D. S., Chan, E., Fueger, B., Czernin, J., & Sawyers, C. L. (2006) · Nature Medicine · doi:10.1038/nm1337 · Cited by 604
Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin
Awasthi, S., Cheng, J., Singhal, S. S., Saini, M. K., Pandya, U., Pikula, S., Bandorowicz-Pikula, J., Singh, S. V., Zimniak, P., & Awasthi, Y. C. (2000) · Biochemistry · doi:10.1021/bi992964c · Cited by 159
Self-citationRLIP76 is a major determinant of radiation sensitivity
Awasthi, S., Singhal, S. S., Yadav, S., Singhal, J., Drake, K., Nadkar, A., Zajac, E., Wickramarachchi, D., Rowe, N., Yacoub, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0968 · Cited by 88 · cited 1×
“We have previously shown that RLIP76 can be delivered to tissues invivo by injecting RLIP76 encapsulated in proteoliposomes.(9) RLIP76 / mice were injected with 200 lg/0.”
BackgroundSelf-citationHsf-1 and POB1 induce drug sensitivity and apoptosis by inhibiting Ralbp1
Singhal, S. S., Yadav, S., Drake, K., Singhal, J., & Awasthi, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708703200 · Cited by 55
Self-citation
Cited by
Doxorubicin pathways: pharmacodynamics and adverse effects
Thorn, C. F., Oshiro, C., Marsh, S., Hernandez-Boussard, T., McLeod, H., Klein, T. E., & Altman, R. B. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833ffb56 · Cited by 1,648
Singhal, S. S., Wickramarachchi, D., Yadav, S., Singhal, J., Leake, K., Vatsyayan, R., Chaudhary, P., Lelsani, P., Suzuki, S., Yang, S., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0699 · Cited by 62
Self-citationRlip depletion prevents spontaneous neoplasia in TP53 null mice
Awasthi, S., Tompkins, J., Singhal, J., Riggs, A. D., Yadav, S., Wu, X., Singh, S., Warden, C., Liu, Z., Wang, J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719586115 · Cited by 33
Self-citationSinghal, S. S., Figarola, J., Singhal, J., Leake, K., Nagaprashantha, L., Lincoln, C., Gabriel Gugiu, B., Horne, D., Jove, R., Awasthi, S., et al. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.08.020 · Cited by 20
“Cells were subsequently dissolved in 100 mL dimethyl-sulfoxide with gentle shaking for 2 h at room temperature, followed by measurement of optical density at 570 nm [13].”
MethodBennani-Baiti, B., Toegel, S., Viernstein, H., Urban, E., Noe, C. R., & Bennani-Baiti, I. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139101 · Cited by 20
Metadata
- Authors
- Singhal, S. S., Sehrawat, A., Sahu, M., Singhal, P., Vatsyayan, R., Rao Lelsani, P. C., Yadav, S., & Awasthi, S.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2009-12-22
- Volume
- 126
- Issue
- 6
- Pages
- 1327-1338
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2051997184
- Cited by
- 57
- References
- 5
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer. https://app.cochat.ai/papers/10.1002/ijc.24767
- The paper
- Singhal, S. S., Sehrawat, A., Sahu, M., Singhal, P., Vatsyayan, R., Rao Lelsani, P. C., Yadav, S., & Awasthi, S. (2010). Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer. International Journal of Cancer. https://doi.org/10.1002/ijc.24767
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.